Acorda Therapeutics Inc (NASDAQ:ACOR)

35.17
BATS BZX Real-Time Price
As of 1:56pm ET
 +0.16 / +0.46%
Today’s Change
28.26
Today|||52-Week Range
45.45
-13.95%
Year-to-Date

Today’s Trading

Previous close35.01
Today’s open35.08
Day’s range34.64 - 35.65
Volume285,710
Average volume (3 months)741,847
Market cap$1.4B
Dividend yield--
Data as of 1:41pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-170.80%
Earnings growth (next 5 years)+15.50%
Revenue growth (last year)+19.34%
P/E ratio83.6
Price/Sales4.19
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACHNAchillion Pharmaceut...-0.37-2.96%
ZIOPZIOPHARM Oncology In...+0.34+2.88%
GWPHGW Pharmaceuticals P...-1.12-1.40%
CMRXChimerix Inc-0.34-0.84%
Data as of 1:56pm ET, 03/03/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account